Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis

Antonio Ascione, N. Caporaso, Mario Melazzini et al.|Infection|2018

Cited by 8